Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Oxidative Stress of Ferric Carboxymaltose in IDA
NCT01290315Phase 2Completed
- Sponsor
- American Regent, Inc.
- Start
- Aug 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Aug 2009; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01290315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290315.